Work

Recent Advances in the Treatment of Eosinophilic Esophagitis

Year: 2023

Type: review

Source: The Journal of Allergy and Clinical Immunology In Practice

DOI: 10.1016/j.jaip.2023.06.035

Authors: Amiko M. Uchida, Caitlin M. Burk, Marc E. Rothenberg, Glenn T. Furuta, Jonathan M. Spergel

Institutions: University of Utah, Harvard University, Massachusetts General Hospital, University of Cincinnati, Children's Hospital Colorado, University of Colorado Anschutz, Children's Hospital of Philadelphia, University of Pennsylvania

Language: English

Topic: Eosinophilic Esophagitis

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi, Teva Pharmaceutical Industries, Children's Hospital Colorado, Novartis Pharmaceuticals Corporation, American Partnership for Eosinophilic Disorders, Regeneron Pharmaceuticals, Campaign Urging Research for Eosinophilic Disease, Rare Diseases Clinical Research Network, Eosinophilic Family Coalition, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G1335197882, Consortium of Eosinophilic Gastrointestinal Disease Researchers, G195379789, G2914029385, G2976362549, G3226332870, G3500416612, Regulation of Gastrointestinal Eosinophils, Early life factors, gene-environment interaction and eosinophilic esophagitis, G4985645376, G6480079429, Roles of FFAR 3-SCFA axis in Th2 cytokine production by tissuelymphocytes in EoE, G7383396752, G7647928860, G8811348018, G897547723, Research Training in Pulmonary Immunology and Allergy at Massachusetts General Hospital, Epithelial Genes in Allergic Inflammation, Genetic and Immunological Dissection of Eosinophilic Esophagitis

OpenAlex ID: W4382405089

FWCI: 1.401

Cites: 96

Cited by: 24

Related to: 10